Molecular Oncology
Volume 2, Issue 1 , Pages 20-32 , June 2008

Trends in the global funding and activity of cancer research

  • Seth Eckhouse

      Affiliations

    • European Cancer Research Managers Forum, London, UK
    • ,
  • Grant Lewison

      Affiliations

    • School of Library, Archive and Information Studies, University College London, Gower Street, London WC1E 6BT, UK
    • ,
  • Richard Sullivan

      Affiliations

    • European Cancer Research Managers Forum, London, UK
    • Department of Social Policy (Population, Health and Society), London School of Economics and Political Science, Houghton Street, London WC2A 2AE, UK
    • Corresponding Author InformationCorresponding author. Department of Social Policy (Population, Health and Society), London School of Economics and Political Science, Houghton Street, London WC2A 2AE, UK. Tel.: +44 7720398401.
    • RS was formally Director of Clinical Programmes at Cancer Research UK and is now a Consultant at PHG Foundation, Cambridge.

Received 14 March 2008 ,Accepted 17 March 2008.

References 

  1. Canadian Cancer Research Alliance . Cancer Research Investment in Canada, 2005. Canadian Cancer Research Alliance; September 2007;
  2. Cowdry EV. Financing cancer research. Science. 1947;105(2716):53–57
  3. Cheng MH. Cancer research funding in Asia. Molecular Oncology. 2007;1:135–137
  4. Cambrosio A, et al. Mapping the emergence and development of translational cancer research. European Journal of Cancer. 2006;42:3140–3148
  5. CMR International . 2006/2007 Pharmaceutical R&D FactBook. CMR; 2006;
  6. Centre for Medicines Research International . The 2005/2006 CMR International R&D Factbook. Surrey: CMR; 2006;
  7. Chubin DE, Studer KE. The politics of cancer. Theory and Society. 1978;6(1):55–74
  8. De Laine M. Cutbacks in budget for 2008 ‘damaging’ for research, Danish Universities say. Research Europe. February 15, 2008;14:
  9. Eckhouse S, Sullivan R. A Survey of Public Funding of Cancer Research in the European Union. PLoS Medicine. 2006;3(7):e267
  10. European Strategy Forum on Research Infrastructures. European Roadmap for Research Infrastructures Report, 2006, Luxembourg.
  11. Economist. The business of giving. A survey of wealth and philanthropy. February 25th, 2006.
  12. Faulkner W, Senker J. An approach supported by numerous policy studies. In: Knowledge Frontiers: Public Sector Research and Industrial Innovation in Biotechnology. Oxford: Clarendon; 1995;
  13. Full report at www.ecrmforum.org.
  14. Fujimura JH. The molecular biological bandwagon in cancer research: where social worlds meet. Social Problems. 1988;35(3):261–283
  15. Giving More for Research in Europe: Strengthening the Role of Philanthropy in the Financing of Research, Brussels, 27–28 March 2006, EUR 2261 EN.
  16. Greenberg DS. The Politics of Pure Science. NY: New American Library; 1967;200 pp.
  17. Hamilton WD. The genetical evolution of social behaviour I and II. Journal of Theoretical Biology. 1964;7:1–52
  18. Humpries N. Varieties of altruism – and the common ground between them. Social Research. 1997;64:199–209
  19. Hartmann M, Hartmann-Vareillas F. The clinical trials Directive: how is it affecting Europe's non-commercial research?. PLoS Clinical Trials. 2006;1(2):e13
  20. Hearn J, Sullivan R. The impact of the ‘Clinical Trials’ directive on the cost and conduct of non-commercial cancer trials in the UK. European Journal of Cancer. 2007;43:8–13
  21. Jungbluth S, et al. Europe combating cancer: the European Union's commitment to cancer research in the 6th Framework Programme. Molecular Oncology. 2007;1:14–18
  22. Kaplan, W., Laing, R. November 2004. Priority Medicines for Europe and the World. WHO/EDM/PAR/2004.7.
  23. Lewison G, Paraje G. The classification of biomedical journals by research level. Scientometrics. 2004;60:145–157
  24. Laredo P. The networks promoted by the framework programme and the questions they raise about its formulation and implementation. Research Policy. 1998;27:589–598
  25. Mowery DC. The changing structure of the US national innovation system: implications for international conflict and co-operation in R&D policy. Research Policy. 1998;27:639–654
  26. Niederhuber JE. A look inside the National Cancer Institute budget process: implications for 2007 and beyond. Cancer Research. 2007;67:3
  27. Presentation by Dr Octavi Quintana Trias (Director, DG Research) Biotechnology for Health Future Perspectives to EC-US Task Force for Biotechnology, 19 July 2006.
  28. Philanthropic giving as a % of GDP, 1995–2002. John Hopkins Comparative Nonprofit Sector Project.
  29. Science and Innovation Policy. Key Challenges and Opportunities, OECD. Meeting of the Committee for Scientific and Technological Policy at Ministerial Level 29–30 January 2004 (Report).
  30. Pavitt K. The inevitable limits of EU R&D funding. Research Policy. 1998;27:559–568
  31. Rairio, K. ERA – From Casualty Ward to Intensive Care, Research Eur 20007, 20 September, 6–8.
  32. Report of the Independent Expert Group on R&D and the Innovation Appointed Following the Hampton Court Summit and Chaired by Mr Esko Aho, Creating an Innovative Europe, January 2006, EUR 22005.
  33. See http://cordis.europa.eu/lifescihealth/cancer/cancer-pro-calls.htm for the cancer proposals funded under FP6.
  34. Saunders C, et al. Beyond scientific rigour: funding cancer research of public value. Health Policy. 2007;84:234–242
  35. US Senate. Conquest of Cancer Act, 1971. Hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, 92nd Congress, Washington, DC 1971.
  36. Snow CP. The Two Cultures and the Scientific Revolution. New York:. second ed.. Cambridge University Press; 1963;
  37. Trivers RL. The evolution of reciprocal altruism. Quarterly Review of Biology. 1971;46(1):35–57
  38. Wright K. Charitable change – creating a new culture of giving for Britain. LSE Magazine Winter. 2000;19–21

☆ This work was supported by European Cancer Research Managers Forum (ECRM) and a previous EU 5th Framework grant (QLG1-CT-2002-30203/ECRM).

PII: S1574-7891(08)00040-9

doi: 10.1016/j.molonc.2008.03.007

Molecular Oncology
Volume 2, Issue 1 , Pages 20-32 , June 2008

Article Tools

* Image Usage & Resolution